Marrache et al. reported that the nanophotosensitizer resulted in increased levels of IL-18 secretions by breast cancer cells upon photoactivation, which in turn facilitated the production of interferon-gamma (IFN-γ) of activated DCs [89]. Here, IFNG is linked to breast carcinoma.